Patents by Inventor Bruce G. Haffty

Bruce G. Haffty has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY USING RILUZOLE TO ENHANCE TUMOR SENSITIVITY TO IONIZING RADIATION
    Publication number: 20240042033
    Abstract: Disclosed is a method of treating a tumor in a patient, comprising (a) administering riluzole in an amount effective to sensitize the tumor cells to ionizing radiation, and (b) irradiating the tumor cells with ionizing radiation in a dose effective to reduce tumor cell growth. The method can further comprise administering an effective amount of one or more additional therapeutic agents.
    Type: Application
    Filed: October 18, 2023
    Publication date: February 8, 2024
    Applicant: Rutgers, The State University of New Jersey
    Inventors: Atif J. Khan, Suzie Chen, James S. Goydos, Bruce G. Haffty
  • Combination therapy using riluzole to enhance tumor sensitivity to ionizing radiation
    Patent number: 11813331
    Abstract: Disclosed is a method of treating a tumor in a patient, comprising (a) administering riluzole in an amount effective to sensitize the tumor cells to ionizing radiation, and (b) irradiating the tumor cells with ionizing radiation in a dose effective to reduce tumor cell growth. The method can further comprise administering an effective amount of one or more additional therapeutic agents.
    Type: Grant
    Filed: December 8, 2021
    Date of Patent: November 14, 2023
    Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventors: Atif J. Khan, Suzie Chen, James S. Goydos, Bruce G. Haffty
  • COMBINATION THERAPY USING RILUZOLE TO ENHANCE TUMOR SENSITIVITY TO IONIZING RADIATION
    Publication number: 20220096636
    Abstract: Disclosed is a method of treating a tumor in a patient, comprising (a) administering riluzole in an amount effective to sensitize the tumor cells to ionizing radiation, and (b) irradiating the tumor cells with ionizing radiation in a dose effective to reduce tumor cell growth. The method can further comprise administering an effective amount of one or more additional therapeutic agents.
    Type: Application
    Filed: December 8, 2021
    Publication date: March 31, 2022
    Applicant: Rutgers, The State University of New Jersey
    Inventors: Atif J. Khan, Suzie Chen, James S. Goydos, Bruce G. Haffty
  • Combination therapy using riluzole to enhance tumor sensitivity to ionizing radiation
    Patent number: 11229704
    Abstract: Disclosed is a method of treating a tumor in a patient, comprising (a) administering riluzole in an amount effective to sensitize the tumor cells to ionizing radiation, and (b) irradiating the tumor cells with ionizing radiation in a dose effective to reduce tumor cell growth. The method can further comprise administering an effective amount of one or more additional therapeutic agents.
    Type: Grant
    Filed: November 20, 2020
    Date of Patent: January 25, 2022
    Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventors: Atif J. Khan, Suzie Chen, James S. Goydos, Bruce G. Haffty
  • COMBINATION THERAPY USING RILUZOLE TO ENHANCE TUMOR SENSITIVITY TO IONIZING RADIATION
    Publication number: 20210138067
    Abstract: Disclosed is a method of treating a tumor in a patient, comprising (a) administering riluzole in an amount effective to sensitize the tumor cells to ionizing radiation, and (b) irradiating the tumor cells with ionizing radiation in a dose effective to reduce tumor cell growth. The method can further comprise administering an effective amount of one or more additional therapeutic agents.
    Type: Application
    Filed: November 20, 2020
    Publication date: May 13, 2021
    Applicant: Rutgers, The State University of New Jersey
    Inventors: Atif J. Khan, Suzie Chen, James S. Goydos, Bruce G. Haffty
  • Combination therapy using riluzole to enhance tumor sensitivity to ionizing radiation
    Patent number: 10864271
    Abstract: Disclosed is a method of treating a tumor in a patient, comprising (a) administering riluzole in an amount effective to sensitize the tumor cells to ionizing radiation, and (b) irradiating the tumor cells with ionizing radiation in a dose effective to reduce tumor cell growth. The method can further comprise administering an effective amount of one or more additional therapeutic agents.
    Type: Grant
    Filed: February 15, 2013
    Date of Patent: December 15, 2020
    Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventors: Atif Jalees Khan, Suzie Chen, James S. Goydos, Bruce G. Haffty
  • ASSAY FOR THE DETECTION OF RECURRENCE IN BREAST CANCER USING THE NOVEL TUMOR SUPPRESSOR DEAR1
    Publication number: 20120058901
    Abstract: Certain aspects of the present invention relate to new diagnostic and prognostic methods involving DEAR1, a gene is located on the short arm of human chromosome 1. Specifically, analysis of expression or structure of this gene for prognosis or recurrence risk assessment is disclosed.
    Type: Application
    Filed: February 12, 2010
    Publication date: March 8, 2012
    Inventors: Ann M. Killary, Steven T. Lott, Bruce G. Haffty